Risk Factors for Outcomes After Microvascular Decompression for Trigeminal Neuralgia

Jia Shi1, Yitao Qian1, Wei Han1

  • 1Department of Neurosurgery, Third Affiliated Hospital of Soochow University, Changzhou, China.

World Neurosurgery
|January 21, 2020
PubMed
Abstract

Insights

Younger patients with trigeminal neuralgia (TN) experience worse pain outcomes after microvascular decompression (MVD). Poor preoperative pain control and multivessel compression are key risk factors for recurrence.

Area of Science:

  • Neurosurgery
  • Neurology
  • Pain Management

Background:

  • Microvascular decompression (MVD) is the most effective long-term surgical treatment for trigeminal neuralgia (TN).
  • Understanding risk factors for suboptimal pain control post-MVD is crucial for improving patient outcomes.

Purpose of the Study:

  • To identify risk factors associated with poor pain control after MVD in patients with typical TN.
  • To analyze the long-term efficacy of MVD for TN based on identified risk factors.

Main Methods:

  • Retrospective analysis of 184 patients with typical TN who underwent MVD.
  • Data collected from operative records and case notes, with follow-up ranging from 3 to 48 months.
  • Binary logistic regression and receiver operating characteristic (ROC) curve analysis were used to identify risk factors.

Main Results:

  • 72.3% of patients achieved pain freedom post-MVD; 27.7% experienced poor pain control.
  • Younger age (OR, 0.90), poor preoperative pain control (BNI score >IV, OR, 52.03), and intraoperative multivessel compression (OR, 2.49) were significant risk factors for poor outcomes.
  • Combined compression of the superior cerebellar artery and petrosal vein was an independent predictor of poor outcomes (OR, 5.69).

Conclusions:

  • Younger patients with TN are at higher risk for worse long-term pain outcomes following MVD.
  • Preoperative pain severity and the presence of multivessel compression, particularly involving the superior cerebellar artery and petrosal vein, are critical factors associated with MVD treatment failure.